<DOC>
	<DOCNO>NCT00165230</DOCNO>
	<brief_summary>The purpose study find effect , good bad , thalidomide temodar patient neuroendocrine tumor .</brief_summary>
	<brief_title>Thalidomide Combination With Temodar Patients With Neuroendocrine Tumors</brief_title>
	<detailed_description>- Patients receive thalidomide orally daily continuously unless experience significant side effect . Temodar give orally day one week , follow one week break period . This one week on/one week schedule continue duration treatment unless significant side effect . - After eight week ( 2 cycle ) CT scan perform see treatment affect patient 's tumor . Patients continue take study drug unless evidence tumor growth . - Regular blood test do weekly first two month make sure treatment result serious side effect . If side effect first two month , blood test may decrease frequency every two week . - Immediately patient complete study evaluate physical exam , blood work , CT scan . The follow-up consist clinic visit phone call every 3 month .</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Histologically confirm locally unresectable metastatic neuroendocrine tumor exclude small cell carcinoma Prior treatment chemoembolization cryotherapy allow Radiotherapy allow complete 4 week prior study . Measurable disease define RECIST criterion Age great equal 18 year . ECOG performance status less equal 2 ANC &gt; 1,500/mm3 Platelet Count &gt; 100,000/mm3 Hemoglobin &gt; 9 g/dl Serum creatinine &lt; 1.5 x ULN Total bilirubin &lt; 2 x ULN SGOT SGPT &lt; 2 x ULN Alkaline phosphatase &lt; 2 x ULN Life expectancy great 12 week Clinically symptomatic central nervous system metastases carcinomatous meningitis Myocardial infarction past 6 month Major surgery past two week Uncontrolled serious medical psychiatric illness Insufficient recovery active toxicity prior therapy Active nonmalignant systemic disease Frequent vomit medical condition could interfere oral medication intake Known HIV positivity AIDSrelated illness Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>thalidomide</keyword>
	<keyword>temodar</keyword>
	<keyword>metastatic neuroendocrine tumor</keyword>
	<keyword>unresectable neuroendocrine tumor</keyword>
</DOC>